Integrelin synthetic peptide inhibitor of the platelet fibrinogen receptor GPIIb/IIIa data

The South San Francisco company presented data showing a dose-dependent effect in both indications.

Ischemic episodes, as recorded by Holter monitoring of 110 patients withdrawn from the drug (45 µg/kg

Read the full 303 word article

How to gain access

Continue reading with a
two-week free trial.